Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
GRCE
GRCE News & Events
-
Add to Watchlist
Trade GRCE
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
GRCE News
Grace's Drug FDA Rejection Leads to Stock Plunge
1d ago
stocktwits
Grace Therapeutics Faces FDA Rejection for New Drug Application
1d ago
NASDAQ.COM
FDA Rejects Grace Therapeutics Drug Application
1d ago
stocktwits
FDA Issues Complete Response Letter for GTx-104 Application
2d ago
Newsfilter
GRACE THERAPEUTICS, INC - FDA WAIVES REQUEST FOR FURTHER CLINICAL DATA ON GTX-104 NDA
2d ago
moomoo
Grace Therapeutics' GTx-104 NDA Accepted by FDA, Key Decision Approaches
3d ago
stocktwits
Grace Therapeutics Q3 Earnings Beat Expectations
Feb 12 2026
seekingalpha
Biotech Stocks Soar in After-Hours Trading: TCMD, BDSX, and EXAS Take the Lead
Nov 04 2025
NASDAQ.COM
Show More News
GRCE Events
04/23 14:00
Grace Therapeutics Shares Drop 48% to $2.24
Shares of Grace Therapeutics are down $2.07, or 48%, to $2.24 after the FDA issued a Complete Response Letter for the company's New Drug Application for GTx-104 for the treatment of patients with aSAH.
Show More Events
GRCE Monitor News
FDA Issues Complete Response Letter for Grace Therapeutics' GTx-104
Apr 23 2026
GRCE Earnings Analysis
No Data
People Also Watch
